Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Not Confirmed
Not Confirmed
03-05 September, 2025
Not Confirmed
Not Confirmed
04-06 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Coatings TrendsCoatings Trends
Industry Trade Show
Not Confirmed
03-05 September, 2025
Industry Trade Show
Not Confirmed
04-06 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
02 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/02/3142481/0/en/Biogen-and-Stoke-Therapeutics-Present-Data-at-the-36th-International-Epilepsy-Congress-that-Support-the-Potential-for-Zorevunersen-to-be-the-First-Disease-Modifying-Medicine-for-Dr.html
02 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-02/stoke-therapeutics-and-biogen-present-data-at-the-36th-international-epilepsy-congress-that-support
29 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/eisai-secures-highly-anticipated-fda-green-light-leqembi-iqlik-autoinjector-teeing-home
28 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-28/zurzuvaetm-zuranolone-becomes-first-and-only-mhra-licensed-treatment-for-mothers-with-post-natal-depression
25 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-25/stoke-therapeutics-and-biogen-announce-presentations-of-clinical-data-from-studies-of-zorevunersen-f
11 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/11/3130760/0/en/Biogen-and-Stoke-Therapeutics-Announce-First-Patient-Dosed-in-Phase-3-EMPEROR-Study-of-Zorevunersen-a-Potential-Disease-Modifying-Treatment-for-Dravet-Syndrome.html
REF. STANDARDS & IMPURITIES
Inspections and registrations
ABOUT THIS PAGE
Biogen is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of IDEC-114 (GALIXIMAB);CHEMERIC (MACAQUE/HUMAN) MONOCLONAL ANTIBODY TO CD80 (B7.1) bulk offered by Biogen
Find a price of MURINE MONOCLONAL ANTIBODY (2B8) TO CD20 bulk offered by Biogen
Find a price of HUMANIZED MONOCLONAL ANTIBODY (IDEC-131) (CHO CELLS, IDEC) TO CD40L (CD 154) bulk offered by Biogen